VenoStent

VenoStent is developing a resorbable, shape memory polymer external wrap for blood vessels

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Houston, TX, USA
  • Currency USD
  • Founded September 2017
  • Employees 5
  • Incorporation Type C-corp
  • Website venostent.com

Company Summary

Over 60% of blood vessels used in dialysis creation surgery collapse within 12 months (5 years for coronary bypass), risking the lives of 5 million patients every year. Our absorbable wrap goes around these vessels, preventing that collapse. Our product worked in every metric we tested in large animals. It costs Medicare $20,000 every time this surgery fails. At $5k price for 830k US surgeries that can use our product, this is a $4B+ US market.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free